María Vanesa G. C.
- Country
- Spain
- Department
- Medical Oncology
Research Overview
- Phase 2 Study of ABBV-706 and Atezolizumab versus Standard of Care in Patients with Previously Untreated Extensive-Stage Small Cell Lung Cancer
- Phase 2/3 Study of EIK1001 Combined with Pembrolizumab and Chemotherapy in Stage IV Non-Small Cell Lung Cancer
- Phase 2 Study Evaluating Safety and Tolerability of Alisertib Combined with Paclitaxel in Patients with Small Cell Lung Cancer
Data & Insights
Has run more than one trial at 39 of 188 partner sites.
Specializations
Oncology Focus
This investigator specializes in the treatment of head and neck cancers, with particular emphasis on squamous cell carcinoma management and innovative therapeutic approaches.
- Head and neck surgical oncology
- Post-resection treatment strategies
- Advanced cancer therapeutics
The investigator's work centers on developing enhanced treatment protocols for surgically treated head and neck cancer patients.
Therapeutic Innovation
The researcher focuses on integrating radiotherapy with novel therapeutic agents to improve patient outcomes in locally advanced head and neck cancer cases.
- Combined therapy approaches
- Treatment optimization
- Disease-free survival enhancement
Their work emphasizes the development of treatment strategies for high-risk patients requiring specialized therapeutic approaches.
Clinical Expertise
The investigator demonstrates particular interest in post-surgical cancer care and the management of complex head and neck cancer cases.
- Post-operative care protocols
- Risk assessment strategies
- Alternative treatment pathways
Their clinical focus includes developing treatment options for patients who require specialized therapeutic considerations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.